These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5784376)

  • 1. [Searching for a new therapeutic principle. Experience with hepatic therapeutic agent Legalon].
    Schopen RD; Lange OK; Panne C; Kirnberger EJ
    Med Welt; 1969 Apr; 20(15):888-93. PubMed ID: 5784376
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of carsil and legalon in treating chronic liver diseases].
    Brailski Kh; Chernev K; Etŭrska M; Donov M; Velev G
    Vutr Boles; 1986; 25(3):43-9. PubMed ID: 3765578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
    Reutter FW; Haase W
    Schweiz Rundsch Med Prax; 1975 Sep; 64(36):1145-51. PubMed ID: 1099576
    [No Abstract]   [Full Text] [Related]  

  • 4. [Silymarin in chronic liver diseases].
    Müscher CH
    Ther Ggw; 1972 Dec; 111(12):1768-70 passim. PubMed ID: 4569030
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical investigation of silymarin in chronic liver diseases (author's transl)].
    Realini S; Gonvers JJ; Hofstetter JR
    Schweiz Rundsch Med Prax; 1975 May; 64(19):595-8. PubMed ID: 51497
    [No Abstract]   [Full Text] [Related]  

  • 6. [Glucocorticoids in chronic liver diseases].
    Maier KP; Talke H; Gerok W
    Dtsch Med Wochenschr; 1975 Mar; 100(11):560-3. PubMed ID: 1116441
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of hepatic diseases in ambulatory medicine. Multicenter studies].
    Martines G; Mingrino GC; Cagnetta G; Copponi V
    Clin Ter; 1980 Jan; 92(1):33-58. PubMed ID: 7449307
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of the Romanian product Silimarina in the treatment of chronic liver diseases.
    Tănăsescu C; Petrea S; Băldescu R; Macarie E; Chiriloiu C; Purice S
    Med Interne; 1988; 26(4):311-22. PubMed ID: 3072661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions].
    Maleev A; Tsvetkova V; Krŭstev Z; Kostova N; Lukanov L
    Vutr Boles; 1985; 24(5):39-43. PubMed ID: 4090451
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic action of S-adenosylmethionine in some chronic hepatopathies].
    Labò G; Gasbarrini GB
    Minerva Med; 1975 May; 66(33):1563-70. PubMed ID: 1143692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical treatment of acute and chronic liver diseases].
    Szabb L
    Z Allgemeinmed; 1972 Feb; 48(4):182-4. PubMed ID: 5015143
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thiomesterone and liver function].
    Pickert H
    Med Klin; 1968 Aug; 63(31):1222-6. PubMed ID: 5719699
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical study of citiolone, cyto-membranous hepatic protector].
    Varay A; Castel A; Bloch J
    Therapeutique; 1970 Dec; 46(10):993-5. PubMed ID: 5511936
    [No Abstract]   [Full Text] [Related]  

  • 14. [Observations on the treatment of chronic inflammatory liver diseases with the preparation Hepasteril B comp].
    Busse K; Otremba P
    Soins; 1970; 15(7):2608-13. PubMed ID: 4918343
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of liver diseases using Silymarin (Legalon)].
    Milosavljevic Z
    Ther Ggw; 1973 Jun; 112(6):968 passim. PubMed ID: 4200154
    [No Abstract]   [Full Text] [Related]  

  • 16. [A contribution to the treatment of chronic liver diseases (author's transl)].
    Möller E; Schmitt R
    Med Klin; 1976 Oct; 71(43):1831-5. PubMed ID: 825708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of hepatoses. Therapeutic use of Silymarin].
    Schopen RD; Lange OK
    Med Welt; 1970 Apr; 15():691-8. PubMed ID: 5523243
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experimentation with Aïcamine in hepatic insufficiency].
    Négret JP
    Bord Med; 1972 Apr; 5(8):973-6. PubMed ID: 5053280
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experiences in liver diseases (specially in patients with fatty liver due to alcoholism and food poisoning) under monotherapy with ornithine aspartate].
    Hunold W
    Z Allgemeinmed; 1973 Apr; 49(10):469-72. PubMed ID: 4580434
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of glucocorticoid therapy in liver diseases].
    Möller E; Brinkmann W; Weber O
    Med Welt; 1967 Apr; 14():884-9. PubMed ID: 5585085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.